Mr. Reid Whitlock, a Statistician in the Chronic Diseases Innovation Center at Seven Oaks General Hospital in Winnipeg, Manitoba, Canada, reviews results of his study appearing in the January 2020 issue of Mayo Clinic Proceedings. He found that Metformin was safe to use in patients with type 2 diabetes and chronic kidney disease and that this offers patients earlier benefit from metformin’s cardiovascular protection. Available at: https://mayocl.in/2LzHkWs
Video Rating: / 5
Video Rating: / 5
